"10.1371_journal.pone.0039434","plos one","2012-07-03T00:00:00Z","Gregory A Light; Neal R Swerdlow; Anthony J Rissling; Allen Radant; Catherine A Sugar; Joyce Sprock; Marlena Pela; Mark A Geyer; David L Braff","VISN-22 Mental Illness, Research, Education, and Clinical Center (MIRECC), San Diego VA Health Care System, La Jolla, California, United States of America; Department of Psychiatry, University of California San Diego, La Jolla, California, United States of America; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, United States of America; Departments of Psychiatry and Biostatistics, University of California Los Angeles, Los Angeles, California, United States of America","Conceived and designed the experiments: GAL NRS MAG DLB. Performed the experiments: GAL JS AJR MP. Analyzed the data: GAL AJR JS AR CAS. Wrote the paper: GAL NRS AJR AR CAS JS MP MAG DLB.","Dr. Light has received compensation from Astellas for one-time participation in a scientific advisory boad unrelated to this study. Dr. Geyer has received compensation from Abbott, Acadia, Addex, Cerca Insights, Merck, Omeros, and Takeda for work unrelated to this study, and holds an equity interest in San Diego Instruments (San Diego, CA). Dr. Swerdlow has received compensation from Neurocrine for work unrelated to this study. This does not alter the authors adherence to all PLoS ONE policies on sharing data and materials. The remaining authors report no financial relationships with commercial interests.","2012","07","Gregory A Light","GAL",9,TRUE,4,4,5,9,TRUE,TRUE,FALSE,0,NA,FALSE
